Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL320682 | 0.88 | ALDH1A1 (0.45) | SOAT1CYP2C19ALDH1A1KMT2ALMNA | |
| SCHEMBL9790011 | 0.87 | SOAT1 (0.39) | SOAT1CYP2C19ALDH1A1KMT2A | |
| SCHEMBL632730 | 0.83 | CYP2C19 (0.36) | SOAT1CYP2C19ALDH1A1KMT2ALMNA | |
| SCHEMBL305795 | 0.81 | KMT2A (0.37) | SOAT1CYP2C19ALDH1A1KMT2ALMNA | |
| SCHEMBL5964972 | 0.79 | ALDH1A1 (0.38) | CYP2C19ALDH1A1KMT2ALMNAHSD17B10 | |
| SCHEMBL12306265 | 0.79 | HDAC6 (0.36) | CYP2C19ALDH1A1KMT2ALMNAHSD17B10 | |
| SCHEMBL11986240 | 0.79 | ALDH1A1 (0.38) | CYP2C19ALDH1A1KMT2ALMNAHSD17B10 | |
| SCHEMBL305794 | 0.79 | CYP2C19 (0.33) | CYP2C19ALDH1A1KMT2ALMNAHSD17B10 | |
| SCHEMBL304788 | 0.79 | ALDH1A1 (0.65) | SOAT1CYP2C19ALDH1A1KMT2ALMNA | |
| SCHEMBL17036113 | 0.79 | CYP2C19 (0.33) | CYP2C19ALDH1A1KMT2ALMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4983320-A | Tertiary amine decomposition catalysts; polyurethane foams | AKZO N.V. (NL) | 1991-01-08 | — | — | US | claimed |